Real-World Study Illuminates Shifting CLL Treatment Trends

An analysis of real-world data regarding the treatment of patients with chronic lymphocytic leukemia revealed that standards of care are shifting from chemoimmunotherapy to targeted therapies. These findings were presented as a poster at the 2021 ASH Annual Meeting. “As more therapies enter the clinic, real-world data are important to understand changes in the CLL … Continue reading Real-World Study Illuminates Shifting CLL Treatment Trends